Mobile-health Network Solutions (NASDAQ:MNDR) versus Omnicell (NASDAQ:OMCL) Critical Review

Omnicell (NASDAQ:OMCL) and Mobile-health Network Solutions (NASDAQ:MNDR) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, analyst recommendations, institutional ownership and risk.

Analyst Recommendations

This is a breakdown of current recommendations for Omnicell and Mobile-health Network Solutions, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Omnicell	0	1	7	1	3.00
Mobile-health Network Solutions	1	0	0	0	1.00

Omnicell currently has a consensus price target of $59.86, suggesting a potential upside of 46.32%. Given Omnicell’s stronger consensus rating and higher probable upside, research analysts clearly believe Omnicell is more favorable than Mobile-health Network Solutions.

Earnings and Valuation

This table compares Omnicell and Mobile-health Network Solutions”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Omnicell	$1.18 billion	1.57	$2.05 million	$0.44	92.97
Mobile-health Network Solutions	$7.32 million	2.48	-$3.38 million	N/A	N/A

Omnicell has higher revenue and earnings than Mobile-health Network Solutions.

Institutional & Insider Ownership

97.7% of Omnicell shares are held by institutional investors. 2.9% of Omnicell shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Volatility & Risk

Omnicell has a beta of 0.97, indicating that its share price is 3% less volatile than the S&P 500. Comparatively, Mobile-health Network Solutions has a beta of -1.14, indicating that its share price is 214% less volatile than the S&P 500.

Profitability

This table compares Omnicell and Mobile-health Network Solutions’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Omnicell	1.67%	4.00%	2.46%
Mobile-health Network Solutions	N/A	N/A	N/A

Summary

Omnicell beats Mobile-health Network Solutions on 12 of the 13 factors compared between the two stocks.

About Omnicell

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

About Mobile-health Network Solutions

Mobile-health Network Solutions, an investment holding company, provides telehealth solutions in Singapore. The company operates in two segments, Telemedicine and Other Services, and Sale of Medicine and Medical Devices. It offers MaNaDr platform, a 360-degree healthcare ecosystem, which connects users and service providers through the range of healthcare services and product offerings that can be accessed through the mobile application and website. The company also provides a range of primary healthcare services, including general medical consultations, treatment and management of acute and chronic conditions in adults and children, vaccinations, and health screenings for work permit applications, as well as pre-employment health screening, children's health services, geriatric care services, and minor surgical procedures. In addition, it offers healthcare and wellness-related products through its online e-commerce platform; wholesale distribution of pharmaceutical products to clinics; and MaNaCare, a platform that provides a range of corporate healthcare and wellness services, including GP, specialist and allied healthcare panel services, tele-consultation services, in-person clinics, on-site health screening, and online marketplace and forum, as well as wellness programs to corporate customers. Further, the company develops IT systems on mobile phone and web portals; operates pharmacies, clinics, and drug stores; and offers beauty and other personal care services, as well as other general medical and health services. The company was founded in 2009 and is headquartered in Singapore.